Provided by Tiger Trade Technology Pte. Ltd.

ProShares Pet Care ETF

48.53
-0.4900-1.00%
Post-market: 48.670.1358+0.28%19:30 EDT
Volume:708
Turnover:34.44K
Market Cap:31.55M
PE:- -
High:48.67
Open:48.56
Low:48.53
Close:49.02
52wk High:57.44
52wk Low:45.96
Shares:650.00K
Float Shares:650.00K
Volume Ratio:0.24
T/O Rate:0.11%
Dividend:0.35
Dividend Rate:0.72%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Conflicted on These Consumer Cyclical Names: Chewy (CHWY) and Mercedes-Benz Group (OtherMBGAF)

TIPRANKS
·
Sep 09

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live
·
Sep 08

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS
·
Sep 08

Chewy Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

TIPRANKS
·
Sep 08

Merck KGaA (0O14) Gets a Hold from Barclays

TIPRANKS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 08

Options Volatility and Implied Earnings Moves This Week, September 08 – September 11, 2026

TIPRANKS
·
Sep 07

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Chewy Seen with Solid 2Q Setup After Guidance Cut

Dow Jones
·
Sep 05

Chewy Price Target Cut to $32.00/Share from $40.00 by Mizuho

Dow Jones
·
Sep 05

Wall Street Analysts Are Bullish on Top Consumer Cyclical Picks

TIPRANKS
·
Sep 04

Merck Price Target Raised to $170.00/Share from $150.00 by Wells Fargo

Dow Jones
·
Sep 04

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Chewy price target lowered to $32 from $40 at Mizuho

TIPRANKS
·
Sep 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 04

Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating

MT Newswires Live
·
Sep 04

Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results

TIPRANKS
·
Sep 04

Summit Therapeutics Says it is Beating Merck with Its Cancer Drug

Dow Jones
·
Sep 04